Abordaje diagnóstico en pacientes con talla baja patológica de 2 a 15 años en el servicio de endocrinología del hospital del niño Dr. Francisco De Icaza Bustamante, periodo 2018 al 2022.

Abstract

Background: pathological short stature is one of the most frequent causes of consultation in pediatrics and referral to a pediatric endocrinologist. It is defined as a condition in which a child's height is below - 2 SD of the population average expected for his or her condition. age and sex. Many times, the patient does not have adequate follow-up, however, they require referral to a specialist because short stature is not always pathological and may be due to a constitutional delay in growth and development, familial short stature, delayed intrauterine growth with an adequate recovery pattern. growth, which constitute normal variants, with all this we intend to make known the most frequent causes of pathological short stature and those that are specifically due to endocrine causes. Methodology: observational, descriptive, retrospective cross-sectional study. The sample consisted of 186 patients who met the inclusion criteria according to data collected from the medical records of patients evaluated in the outpatient clinic at the HFIB. Results: patients with pathological short stature (TBP), that is, height below -2.5 PZ, had an average of -3.43 SDS, which presented a prevalence of the female sex in 51.1% added to the second diagnosis. short stature due to Turner Syndrome with 20%; Of all patients with BPD, in 72.2% the bone age was delayed with respect to the chronological age, in 49.5% the etiology of short stature was of endocrinological origin, with total or partial deficiency of growth hormone (GhD being common.), including isolated deficiencies and cases of multiple pituitary hormone deficiency in 28%. Conclusions: the least suspected causes of pathological short stature is endocrine, a sequential follow-up is required for growth assessment, growth velocity is a reliable but less used indicator, in assessing growth, if it is below the 10th percentile, is a pathological growth pattern evident and can be suspected a pathological short stature due to endocrine causes, for patients with pathological short stature at the Dr. Francisco De Icaza Bustamante Children's Hospital, was made a management protocol, the evaluation of the growth hormone (GH) axis wiil be only for patients who met the diagnostic criteria; classifying patients who require more specific complementary tests, thereby saving resources.